This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Dvant Pharma Form D (2026)

Dvant Pharma reported $1,230,400 raised in an SEC Form D filed on 2026-10-13.

Company
Dvant Pharma
Round type
Form D
Date
2026-10-13
Amount
$1.23M
Industry
Biotechnology
Location
Michigan

Summary

The SEC Form D for Dvant Pharma, filed on 2026-10-13, reports $1,230,400 raised. It was listed in the Raise Track Update of 2026-10-14. Filing: https://www.sec.gov/Archives/edgar/data/2158986/000215898626000001/0002158986-26-000001-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/2158986/000215898626000001/0002158986-26-000001-index.htm
    Type: sec filing. Accessed 2026-10-14.
    SEC Form D for Dvant Pharma, Inc., EDGAR filing date 2026-10-13. Reports $1,230,400 of securities sold. It does not name investors or a round type.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-14/
    Type: other verified public source. Accessed 2026-10-14.
    Raise Track Update for 2026-10-14, Section 3 (SEC Form D filings). Lists Dvant Pharma, state MICHIGAN, industry Biotechnology, amount raised $1,230,400.